This metabolite incorporates a PDE selectivity profile comparable to sildenafil and an in vitro potency for PDE5 approximately fifty% of your parent drug. Plasma concentrations of this metabolite are around forty% of All those found for sildenafil, so which the metabolite accounts for approximately twenty% of sildenafil's pharmacologic outcomes.The